A global retrospective study reported that a single hepatic cause of MASLD resulted in HCC in only 12% of cases, while a combination of other hepatic causes was found in 39%
Logan S, Pharaoh GA, Marlin MC, Masser DR, Matsuzaki S, Wronowski B, Yeganeh A, Parks EE, Premkumar P, Farley JA, Owen DB, Humphries KM, Kinter M, Freeman WM, Szweda LI, Van Remmen H, Sonntag WE
Office of Dietary Supplements,
There is currently no clinical evidence showing that transdermal GLP-1 delivery produces meaningful weight loss results
Evidence-based weight loss relies on proven strategies
J.C.Wendl